Profile v ER13 panel device

Ended Awarded Last action

Contract number
W81K0021F0051
Awardee
Awarding agency
Obligated
$118,647

Award facts

Opportunity
  • W81K0021Q0099 Solicitation number
Contract value 100% obligated
$118,647.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Custer Hill, Fort Riley, KS, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 $9,771
Funding Only Action P00011 $19,963
Exercise an Option P00010 $0
Funding Only Action P00009 $19,963
Supplemental Agreement for work within scope P00008 · Urine drug testing $0
Funding Only Action P00007 · Profile v ER 13 panel device FY21 & FY22 DE-obligation of excess funds. -$497
Other Administrative Action P00006 · Urine drug testing $29,734
Supplemental Agreement for work within scope P00005 · Drug testing $9,771
Exercise an Option P00004 · Urine drug testing $0
Other Administrative Action P00003 · Profile v ER 13 panel device- remove GFP clausess $0
Funding Only Action P00002 $19,963
Exercise an Option P00001 $0
Original award $9,981
Show all 13

About this award

The Defense Health Agency awarded a delivery order contract valued at $118,647.15 to Medtox Laboratories Inc. for Profile V ER13 Panel Devices, effective through September 30, 2025. This firm fixed-price delivery order was issued under Medtox's General Services Administration Multiple Award Schedule contract and carries no set-aside designation, indicating open competition. The work will be performed at Custer Hill, Fort Riley, Kansas. Medtox Laboratories Inc., a St. Paul, Minnesota-based subsidiary of Laboratory Corporation of America Holdings, specializes in laboratory testing and diagnostic services, with particular expertise in drug screening panels and clinical testing supplies.

This award reflects Medtox's established track record providing drug screening and laboratory resources to federal health agencies, most notably the Indian Health Service. The Profile V panel device represents a continuation of the company's core business supporting government healthcare and substance abuse screening programs. As a child entity within LabCorp's portfolio, Medtox leverages its parent company's resources while maintaining its specialized focus on supplying critical medical testing resources to federal healthcare facilities. The delivery order structure allows the Defense Health Agency to procure needed medical devices and testing supplies efficiently through an existing indefinite delivery/indefinite quantity vehicle.

Quick answers

Who was awarded contract W81K0021F0051?

W81K0021F0051 was awarded to Medtox Laboratories Inc. by Medical Command (Department of the Army) on April 5, 2021.

How much is contract W81K0021F0051 worth?

The government has obligated $118,647 on W81K0021F0051.

Which agency awarded contract W81K0021F0051?

Medical Command (Department of the Army) awarded W81K0021F0051, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0021F0051 an order under another contract?

Yes. W81K0021F0051 is a delivery order under 47QSWA20D007S, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract W81K0021F0051 competed?

The extent of competition for W81K0021F0051 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award